TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir

NCT01205139 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus

Interventions

DRUG: TMC435
DRUG: TDF
DRUG: TMC435 + TDF
DRUG: TMC435 + TMC278
DRUG: TMC278
DRUG: TMC435

Sponsor

Tibotec Pharmaceuticals, Ireland